Trials / Completed
CompletedNCT04845113
Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children
Idiopathic Purpura Fulminans Associated With Anti-PS Antibodies in Children: a French Multicenter Retrospective Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (actual)
- Sponsor
- University Hospital, Montpellier · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Idiopathic purpura fulminans by anti-protein S antibody is a very rare but potentially extremely serious entity. The data in the literature are poor with only isolated report boxes and a single series of less than 10 boxes. The creation of a larger series of cases would make it possible to better understand this pathology and to offer assistance in diagnosis and management.
Conditions
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2021-07-01
- Completion
- 2021-07-31
- First posted
- 2021-04-14
- Last updated
- 2021-10-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04845113. Inclusion in this directory is not an endorsement.